Healthways Reports Fourth-Quarter 2015 Financial Results
Feb 25, 2016 21:05 pm UTC| Business
NASHVILLE, Tenn., Feb. 25, 2016 -- Healthways (NASDAQ:HWAY) today announced financial results for the fourth quarter and year ended December 31, 2015. Fourth-Quarter 2015 Financial Highlights Revenues of $186.3...
Geron Corporation Reports Fourth Quarter and Annual 2015 Financial Results
Feb 25, 2016 21:05 pm UTC| Business
MENLO PARK, Calif., Feb. 25, 2016 -- Geron Corporation (Nasdaq:GERN) today reported financial results for the fourth quarter and year ended December 31, 2015 and recent events. Fourth Quarter and Year-End 2015 Results...
Transnational Group Announces Retirement of Chief Financial Officer and Board Member Martin Katz
Feb 25, 2016 21:05 pm UTC| Business
LAS VEGAS, Feb. 25, 2016 -- Transnational Group, Inc. (“Transnational”) (OTC:TAMG)today announced that Martin Katz will retire from his position as the Company’s Chief Financial Officer (CFO) and Board member, effective...
Spectranetics Achieves Fourth Quarter 2015 Revenue of $65.2 Million
Feb 25, 2016 21:05 pm UTC| Business
COLORADO SPRINGS, Colo., Feb. 25, 2016 -- The Spectranetics Corporation (NASDAQ:SPNC) today reported financial results for the three months and year ended December31, 2015. Highlights of the quarter, all compared with...
Noodles & Company Announces Fourth Quarter and Fiscal Year 2015 Financial Results
Feb 25, 2016 21:05 pm UTC| Business
BROOMFIELD, Colo., Feb. 25, 2016 -- Noodles Company (NASDAQ: NDLS) today announced financial results for the fourth quarter and fiscal year ended December29, 2015. Key highlights for the fiscal year of 2015 include: ...
Tonix Pharmaceuticals Appoints Chief Financial Officer
Feb 25, 2016 21:05 pm UTC| Business
NEW YORK, Feb. 25, 2016 -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix), which is developing next-generation medicines for fibromyalgia and post-traumatic stress disorder (PTSD), has appointed Bradley...
Feb 25, 2016 21:05 pm UTC| Business
ANN ARBOR, Mich., Feb. 25, 2016 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), a pharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering...